Skip to main content
Clinical Trials/NCT01221142
NCT01221142
Unknown
Phase 3

Pilot Study of Hypothermia for Intracerebral Hemorrhage in Croatia

University of Rijeka1 site in 1 country20 target enrollmentJanuary 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hypothermia
Sponsor
University of Rijeka
Enrollment
20
Locations
1
Primary Endpoint
Neurological outcome
Last Updated
15 years ago

Overview

Brief Summary

In this pilot study the researchers will investigate efficacy of hypothermia in the early stage of treatment patients with primary intracerebral hemorrhage.

Detailed Description

The purpose of this pilot trial is to determine whether hypothermia improves neurological outcome (measured as 3 and 6 months after the onset of symptoms using mRS, GOS and BI) in patients who has suffered a primary intracerebral hemorrhage. The patients with primary intracerebral hemorrhage presented with coma (GCS ≤ 8) and ICH score 2-4 will be included. Induction of hypothermia will be initiated within 6 hours of symptoms onset. Patients will be cooled to core temperature of 34°C during 24 hours using non-invasive temperature management (Cincinnati Sub-Zero). The temperature will be measured continuously by esophageal system. After 24 hours of successful cooling, the target temperature will be gradually raised to achieve slow re-warming of 0.5°C / 2 h until the core temperature reaches 36,5°C. During hypothermia ECG, blood pressure, oxygen saturation and intracranial pressure will be measured continuously and registered every 30 min. The first CT scan of the brain, after initial, will be done early after normothermia is reached.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
June 2012
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ICH score 2-4
  • symptom onset within 6 hours
  • ages 18 - 80

Exclusion Criteria

  • pregnancy
  • hemodynamical unstability
  • recent myocardial infarction
  • systolic blood pressure \< 90 mm Hg

Outcomes

Primary Outcomes

Neurological outcome

Time Frame: 6 months after the onset

Secondary Outcomes

  • Mortality(6 months)
  • The incidence of significant cardiac arrhythmias, infections, severe disturbances of electrolytes(3 days)

Study Sites (1)

Loading locations...

Similar Trials